6-K Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 Q2 2023

Filing Information

Form Type	6-K
Accession Number	`0001213900-23-070415`
Period End Date	20230630
Filing Date	20230824
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	ea183936-6k_collplantbio_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 48 Cash Flow Statement 64 Stockholders Equity 25

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.65M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.28M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	11.41M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	11.19M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$83.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	-	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$22.00K	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	11.41M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	11.19M	shares	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$23.00K	USD	Point-in-time
Trade receivables	`ReceivablesNetCurrent`	$9.00K	USD	Point-in-time
Trade receivables	`ReceivablesNetCurrent`	$10.16M	USD	Point-in-time
Inventories	`InventoryNet`	$1.43M	USD	Point-in-time
Inventories	`InventoryNet`	$1.55M	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$543.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$758.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$34.86M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$31.66M	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$237.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$188.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$3.33M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.71M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.93M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.97M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$216.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$245.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$6.71M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$6.11M	USD	Point-in-time
Total assets	`Assets`	$37.77M	USD	Point-in-time
Total assets	`Assets`	$41.57M	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$763.00K	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$1.13M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$598.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$529.00K	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.44M	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.10M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.75M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.38M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.75M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.49M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.53M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2023 (unaudited) and December 31, 2022; issued and outstanding: 11,405,394 and 11,186,481 ordinary shares as of June 30, 2023 (unaudited) and December 31, 2022, respectively	`CommonStockValue`	$4.96M	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2023 (unaudited) and December 31, 2022; issued and outstanding: 11,405,394 and 11,186,481 ordinary shares as of June 30, 2023 (unaudited) and December 31, 2022, respectively	`CommonStockValue`	$4.87M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$118.10M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$119.72M	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-89.72M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-87.67M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$43.20M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$45.12M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$32.28M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$39.51M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$36.04M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$29.89M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$41.57M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$37.77M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$10.18M	USD	1 Quarter
Revenues	`Revenues`	$10.62M	USD	2 Qtrs
Revenues	`Revenues`	$132.00K	USD	2 Qtrs
Revenues	`Revenues`	$66.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$940.00K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$615.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$43.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$74.00K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$9.57M	USD	1 Quarter
Gross Profit	`GrossProfit`	$9.68M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$23.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$58.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.84M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.68M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.57M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.60M	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$3.17M	USD	2 Qtrs
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$2.84M	USD	2 Qtrs
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$1.32M	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$1.61M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$2.16M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$5.68M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-7.95M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-4.18M	USD	1 Quarter
Financial income (expenses), net	`NonoperatingIncomeExpense`	$-100.00K	USD	1 Quarter
Financial income (expenses), net	`NonoperatingIncomeExpense`	$-192.00K	USD	2 Qtrs
Financial income (expenses), net	`NonoperatingIncomeExpense`	$85.00K	USD	1 Quarter
Financial income (expenses), net	`NonoperatingIncomeExpense`	$-111.00K	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$-8.14M	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$5.76M	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$2.05M	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$-4.29M	USD	1 Quarter
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$0.18	USD	2 Qtrs
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$-0.74	USD	2 Qtrs
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$0.51	USD	1 Quarter
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$-0.39	USD	1 Quarter
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$0.49	USD	1 Quarter
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.39	USD	1 Quarter
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$0.17	USD	2 Qtrs
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.74	USD	2 Qtrs
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	10.94M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.33M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.09M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.37M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.74M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.94M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.09M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.78M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Income (loss)	`ProfitLoss`	$-8.14M	USD	2 Qtrs
Income (loss)	`ProfitLoss`	$2.05M	USD	2 Qtrs
Depreciation and amortization	`Depreciation`	$501.00K	USD	2 Qtrs
Depreciation and amortization	`Depreciation`	$546.00K	USD	2 Qtrs
Interest from Short term deposits	`GainLossOnSaleOfInvestments`	$87.00K	USD	2 Qtrs
Interest from Short term deposits	`GainLossOnSaleOfInvestments`	-	USD	2 Qtrs
Interest from restricted deposits	`InterestExpenseDeposits`	$11.00K	USD	2 Qtrs
Interest from restricted deposits	`InterestExpenseDeposits`	-	USD	2 Qtrs
Share-based compensation to employees and consultants	`EmployeeBenefitsAndShareBasedCompensationNoncash`	$852.00K	USD	2 Qtrs
Share-based compensation to employees and consultants	`EmployeeBenefitsAndShareBasedCompensationNoncash`	$1.05M	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-444.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-727.00K	USD	2 Qtrs
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$10.15M	USD	2 Qtrs
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$-261.00K	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$275.00K	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$155.00K	USD	2 Qtrs
Increase in other accounts receivable and prepaid expenses	`IncreaseDecreaseInPrepaidExpensesOther`	$170.00K	USD	2 Qtrs
Increase in other accounts receivable and prepaid expenses	`IncreaseDecreaseInPrepaidExpensesOther`	$215.00K	USD	2 Qtrs
Decrease in operating right of use assets	`IncreaseDecreaseInOtherOperatingAssets`	$-254.00K	USD	2 Qtrs
Decrease in operating right of use assets	`IncreaseDecreaseInOtherOperatingAssets`	$-220.00K	USD	2 Qtrs
Decrease in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-370.00K	USD	2 Qtrs
Decrease in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-274.00K	USD	2 Qtrs
Decrease in lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-643.00K	USD	2 Qtrs
Decrease in lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-435.00K	USD	2 Qtrs
Decrease in accrued liabilities and other payables	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-22.00K	USD	2 Qtrs
Decrease in accrued liabilities and other payables	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-305.00K	USD	2 Qtrs
Decrease in deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-32.00K	USD	2 Qtrs
Decrease in deferred revenues	`IncreaseDecreaseInDeferredRevenue`	-	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.19M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.17M	USD	2 Qtrs
Capitalization of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Capitalization of intangible assets	`PaymentsToAcquireIntangibleAssets`	$12.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$482.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$678.00K	USD	2 Qtrs
Repayment of a short-term cash deposits	`RepaymentOfAShorttermCashDeposits`	$50.24M	USD	2 Qtrs
Repayment of a short-term cash deposits	`RepaymentOfAShorttermCashDeposits`	-	USD	2 Qtrs
Investment in short term cash deposits and restricted deposits	`PaymentsToAcquireInvestments`	$59.00K	USD	2 Qtrs
Investment in short term cash deposits and restricted deposits	`PaymentsToAcquireInvestments`	$20.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$29.55M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-541.00K	USD	2 Qtrs
Exercise of options and warrants into shares	`ProceedsFromWarrantExercises`	$892.00K	USD	2 Qtrs
Exercise of options and warrants into shares	`ProceedsFromWarrantExercises`	$1.47M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$892.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.47M	USD	2 Qtrs
Exchange differences on cash and cash equivalents, restricted cash and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-727.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents, restricted cash and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-444.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents, restricted cash and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$23.13M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents, restricted cash and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.29M	USD	2 Qtrs
Cash and cash equivalents, restricted cash and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.37M	USD	Point-in-time
Cash and cash equivalents, restricted cash and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.65M	USD	Point-in-time
Cash and cash equivalents, restricted cash and restricted deposits at the end of the period	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$22.37M	USD	Point-in-time
Cash and cash equivalents, restricted cash and restricted deposits at the end of the period	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$36.50M	USD	Point-in-time
Right of use assets recognized with corresponding lease liabilities	`CapitalLeaseObligationsIncurred`	$59.00K	USD	2 Qtrs
Right of use assets recognized with corresponding lease liabilities	`CapitalLeaseObligationsIncurred`	$870.00K	USD	2 Qtrs
Capitalization of Share-based compensation to inventory	`CapitalizationOfSharebasedCompensationToInventory`	$33.00K	USD	2 Qtrs
Capitalization of Share-based compensation to inventory	`CapitalizationOfSharebasedCompensationToInventory`	-	USD	2 Qtrs
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$36.29M	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$22.28M	USD	Point-in-time
Restricted cash	`OtherRestrictedAssets`	-	USD	Point-in-time
Restricted cash	`OtherRestrictedAssets`	$83.00K	USD	Point-in-time
Restricted deposits (including long term)	`RestrictedDepositincludingLongTerm`	-	USD	Point-in-time
Restricted deposits (including long term)	`RestrictedDepositincludingLongTerm`	$212.00K	USD	Point-in-time
Total cash and cash equivalents, restricted cash and restricted deposits	`RestrictedCashAndCashEquivalents`	$36.50M	USD	Point-in-time
Total cash and cash equivalents, restricted cash and restricted deposits	`RestrictedCashAndCashEquivalents`	$22.37M	USD	Point-in-time

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$43.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$45.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$32.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$39.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$36.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.89M	USD	Point-in-time
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$148.00K	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$89.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$174.00K	USD	2 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$1.30M	USD	2 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$744.00K	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$298.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.05M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$594.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$819.00K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-8.14M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$5.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.05M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-4.29M	USD	1 Quarter
Balance	`StockholdersEquity`	$43.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$45.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$32.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$39.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$36.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.89M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.